SyntekaBio, Inc. (KOSDAQ:226330)
South Korea
· Delayed Price · Currency is KRW 3,220.00
-20.00 (-0.62%)
At close: Apr 28, 2026
SyntekaBio Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Cash & Equivalents | 16,346 | 12,066 | 19,668 | 35,342 | 13,709 | Upgrade
|
| Short-Term Investments | - | - | - | - | 39,000 | Upgrade
|
| Cash & Short-Term Investments | 16,346 | 12,066 | 19,668 | 35,342 | 52,709 | Upgrade
|
| Cash Growth | 35.47% | -38.65% | -44.35% | -32.95% | 28.27% | Upgrade
|
| Accounts Receivable | 846.46 | 0.19 | 0.24 | 1.07 | 55.04 | Upgrade
|
| Other Receivables | 38.22 | - | 40.67 | 132.56 | 113.44 | Upgrade
|
| Receivables | 884.69 | 0.19 | 40.91 | 133.63 | 168.48 | Upgrade
|
| Prepaid Expenses | 65.15 | 136.53 | 374.72 | 351.44 | 185.38 | Upgrade
|
| Other Current Assets | 134.93 | 362.17 | 1,896 | 1,670 | 5,131 | Upgrade
|
| Total Current Assets | 17,430 | 12,565 | 21,980 | 37,497 | 58,193 | Upgrade
|
| Property, Plant & Equipment | 28,738 | 30,672 | 30,461 | 17,475 | 9,054 | Upgrade
|
| Other Intangible Assets | 359.22 | 450.39 | 443.85 | 631.99 | 432.98 | Upgrade
|
| Long-Term Accounts Receivable | - | - | 0 | 0 | -0 | Upgrade
|
| Other Long-Term Assets | 6.74 | 28.11 | 31.88 | 85.2 | 198.27 | Upgrade
|
| Total Assets | 46,535 | 43,715 | 52,917 | 55,689 | 67,879 | Upgrade
|
| Accrued Expenses | 868.51 | 428.33 | 357.38 | 249.06 | 226.04 | Upgrade
|
| Short-Term Debt | 7,098 | 7,280 | 1,803 | 10,454 | - | Upgrade
|
| Current Portion of Leases | 12.43 | 21.14 | 262.66 | 415.2 | 198.59 | Upgrade
|
| Other Current Liabilities | 4,265 | 8,571 | 16,975 | 11,136 | 1,464 | Upgrade
|
| Total Current Liabilities | 12,244 | 16,301 | 19,398 | 22,254 | 1,888 | Upgrade
|
| Long-Term Debt | - | - | - | - | 8,152 | Upgrade
|
| Long-Term Leases | 15.58 | 12.39 | 27.94 | 251.65 | 485.11 | Upgrade
|
| Pension & Post-Retirement Benefits | 2,429 | 2,240 | 2,071 | 1,570 | 1,337 | Upgrade
|
| Other Long-Term Liabilities | 67.5 | 218.59 | 191.29 | 152.09 | 28,389 | Upgrade
|
| Total Liabilities | 14,756 | 18,772 | 21,688 | 24,228 | 40,252 | Upgrade
|
| Common Stock | 12,129 | 7,629 | 7,615 | 6,759 | 6,750 | Upgrade
|
| Additional Paid-In Capital | 111,848 | 92,583 | 92,602 | 80,933 | 73,428 | Upgrade
|
| Retained Earnings | -93,833 | -76,293 | -69,018 | -57,452 | -53,051 | Upgrade
|
| Comprehensive Income & Other | 1,634 | 1,024 | 29.3 | 1,221 | 500.14 | Upgrade
|
| Shareholders' Equity | 31,779 | 24,943 | 31,228 | 31,461 | 27,627 | Upgrade
|
| Total Liabilities & Equity | 46,535 | 43,715 | 52,917 | 55,689 | 67,879 | Upgrade
|
| Total Debt | 7,126 | 7,314 | 2,094 | 11,121 | 8,836 | Upgrade
|
| Net Cash (Debt) | 9,219 | 4,752 | 17,574 | 24,222 | 43,873 | Upgrade
|
| Net Cash Growth | 94.01% | -72.96% | -27.45% | -44.79% | 9.50% | Upgrade
|
| Net Cash Per Share | 591.52 | 311.60 | 1227.54 | 1792.34 | 3258.50 | Upgrade
|
| Filing Date Shares Outstanding | 16.57 | 15.26 | 15.23 | 13.52 | 13.5 | Upgrade
|
| Total Common Shares Outstanding | 16.57 | 15.26 | 15.23 | 13.52 | 13.5 | Upgrade
|
| Working Capital | 5,186 | -3,736 | 2,581 | 15,242 | 56,305 | Upgrade
|
| Book Value Per Share | 1918.18 | 1634.71 | 2050.38 | 2327.37 | 2046.46 | Upgrade
|
| Tangible Book Value | 31,420 | 24,493 | 30,784 | 30,829 | 27,194 | Upgrade
|
| Tangible Book Value Per Share | 1896.50 | 1605.20 | 2021.24 | 2280.62 | 2014.38 | Upgrade
|
| Land | 4,954 | 4,954 | 4,954 | 4,936 | 4,936 | Upgrade
|
| Buildings | 22,355 | 22,355 | 22,335 | - | - | Upgrade
|
| Machinery | 9,771 | 9,912 | 7,562 | 6,144 | 5,654 | Upgrade
|
| Construction In Progress | - | - | - | 9,212 | 208 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.